Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves

Vaccine

Volumn 28, Issue 22, 2010, Pages 3784-3792

  Xue, Wenzhi ^a   Ellis, John ^b   Mattick, Debra ^a   Smith, Linda ^a   Brady, Ryan ^a   Trigo, Emilio ^a  

^a Intervet/Schering Plough Animal Health   (United States)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Bovine respiratory diseases; BRSV; BVDV; IBR; Intranasal vaccination; Modified live virus vaccine; PI 3

Indexed keywords

MODIFIED LIVE VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BOVINE DIARRHEA VIRUS; BOVINE HERPES VIRUS; BOVINE RESPIRATORY SYNCYTIAL VIRUS INFECTION; BOVINE VIRAL DIARRHEA; CALF (BOVINE); CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; IMMUNOGENICITY; INFECTIOUS BOVINE RHINOTRACHEITIS; KIDNEY CELL; LEUKOCYTE COUNT; LUNG LESION; NONHUMAN; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS INFECTION; PRIORITY JOURNAL; RECTUM TEMPERATURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SINGLE DRUG DOSE; THROMBOCYTE COUNT; VIRUS SHEDDING;

ADMINISTRATION, INTRANASAL; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY FORMATION; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; DIARRHEA VIRUS 1, BOVINE VIRAL; DIARRHEA VIRUS 2, BOVINE VIRAL; HERPESVIRUS 1, BOVINE; INFECTIOUS BOVINE RHINOTRACHEITIS; NEUTRALIZATION TESTS; PARAINFLUENZA VIRUS 3, BOVINE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, BOVINE; RESPIROVIRUS INFECTIONS; VACCINES, COMBINED; VIRAL VACCINES; VIRUS SHEDDING;

EID: 77952547609     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.03.043     Document Type: Article

References (30)

1. Kelly A.P., and Janzen ED. A review of morbidity and mortality rates and disease occurrence in North America feedlot cattle. Can Vet J 27 (1986) 496-500
2. Barrett D. Bovine respiratory disease-a clinician's perspective. Cattle Pract 6 (1998) 251-255
3. Caldow G., and Nettleton P. Pneumonia: identifying the cause agent. Cattle Pract 8 (2000) 131-134
4. Scott P. Epidemiology and treatment of bovine respiratory in beef cattle. Cattle Pract 5 (1997) 283-288
5. Cusack P.M.V., McMeniman N., and Lean I.J. The medicine and epidemiology of bovine respiratory disease in feedlots. Aust Vet J 81 (2003) 480-487
6. Martin S.W., and Bohac J.G. The association between serological titers in infectious bovine rhinotracheitis virus, bovine viral diarrhea virus, parainfluenza-3 virus, respiratory syncytial virus and treatment for respiratory disease in Ontario feedlot calves. Can J Vet Res 50 (1986) 351-358
7. Baker J.C., and Frey M.L. Bovine respiratory syncytial virus. Vet Clin North Am Large Anim Pract 1 (1985) 259-275
8. Richer L., Marois P., and Lamontagne L. Association of bovine viral diarrhoea virus with multiple viral infections in bovine respiratory disease outbreaks. Can Vet J 29 (1988) 713-717
9. Fulton R.W., Confer A.W., Burge L.J., Perino L.J., d'Offay J.M., Payton M.E., et al. Antibody responses by cattle after vaccination with commercial viral vaccines containing bovine herpesvirus-1, bovine viral diarrhea virus, parainfluenza-3 virus, and bovine respiratory syncytial virus immunogens and subsequent revaccination at day 140. Vaccine 13 (1995) 725-733
10. Schunicht O.C., Booker C.W., Jim G.K., Guichon P.T., Wildman B.K., and Hill B.W. Comparison of a multivalent viral vaccine program versus univalent viral vaccine program on animal health, feedlot performance, and carcass characteristics of feedlot calves. Can Vet J 44 (2003) 43-50
11. 3V, BVDV, and BRSV in experimentally infected calves. Prev Vet Med 66 (2004) 63-77
12. Donkersgoed J.V., van der Hurk J.V., McCartney D., and Harland R.J. Comparative serological responses in calves to eight commercial vaccines against infectious bovine rhinotracheitis, parainfluenza-3, bovine respiratory syncytial, and bovine viral diarrhea viruses. Can Vet J 32 (1991) 727-733
13. Ellis J., Gow S., West K., Waldner C., Rhodes C., Mutwiri G., et al. Responses of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration. J Am Vet Med Assoc 230 (2007) 233-243
14. Gogey S., Fays K.D., Versali M.F., Gautier S., and Thiry E. Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1. Vaccine 22 (2004) 1946-1953
15. Kimman T.G., Westenbrink F., and Staver P.J. Priming for local and systemic antibody memory responses to bovine respiratory syncytial virus: effect of amount of virus, virus replication, route of administration and maternal antibodies. Vet Immunol Immunopathol 22 (1989) 145-160
16. West K., Petrie L., Haines D.M., Konoby C., Clark E.G., Martin K., et al. The effect of formalin-inactivated vaccine on respiratory disease associated with bovine respiratory syncytial virus infection in calves. Vaccine 17 (1999) 809-820
17. West K., Bogdan J., Hamel A., Nayar G., Morley P.S., Haines D.M., et al. A comparison of diagnostic methods for the detection of bovine respiratory syncytial virus in experimental clinical specimens. Can J Vet Res 62 (1998) 245-250
18. West K., Petrie L., Konoby C., Haines D.M., Cortese V., and Ellis J.A. The efficacy of modified-live bovine respiratory syncytial virus vaccines in experimentally infected calves. Vaccine 18 (1999) 907-919
19. Tizard I. Immunity at body surfaces. Veterinary Immunology, An Introduction (2004), WB Saunders Co, Philadelphia 67-74
20. Todd J.D. Intranasal vaccination of cattle against IBR and PI3: field and laboratory observations in dairy, beef, and neonatal calf populations. Dev Biological Standard 33 (1976) 391-395
21. Burroughs A.L., Morrill J.L., and Bostwick J.L. Immune response of dairy cattle to parainfluenza-3 virus in intranasal infectious bovine rhinotracheitis-parainfluenza-3 virus vaccine. Can J Comp Med 46 (1982) 264-266
22. Martin W., Willson P., Curtis R., Allen B., and Acres S. A field trial, of preshipment vaccination, with intranasal infectious bovine rhinotracheitis-parainfluenza-3 vaccines. J Comp Med 47 (1983) 245-249
23. Bowland S.L., and Shewen P.E. Bovine respiratory disease: commercial vaccines currently available in Canada. Can Vet J 41 (2000) 33-48
24. Cortese V. Bovine vaccines and her vaccination programs. In: Smith B. (Ed). Large Animal Internal Medicine (2002), Mosby, Philadelphia 1403-1411
25. Kahrs R.F. Infectious bovine rhinotracheitis and infectious pustular vulvovaginitis. In: Kahrs R.F. (Ed). Viral Diseases Of Cattle (2001), Iowa State University Press, Ames 159-170
26. Kahrs R.F. Parainfluenza type-3. In: Kahrs R.F. (Ed). Viral Diseases Of Cattle (2001), Iowa State University Press, Ames 185-193
27. Bolin S.R., McClurkin A.W., and Coria M.F. Effects of bovine viral diarrhea virus on the percentages and absolute numbers of circulating B and T lymphocytes in cattle. Am J Vet Res 46 (1985) 884-886
28. Ellis J.A., Davis W.C., Belden E.L., and Pratt D.L. Flow cytofluorimetric analysis of lymphocyte subset alterations in cattle infected with bovine viral diarrhea virus. Vet Pathol 25 (1988) 231-236
29. Walz P.H., bell T.G., Wells J.L., and Grooms D.L. Relationship between degree of viremia and disease manifestation in calves with experimentally induced bovine viral diarrhea virus infection. Am J Vet Res 62 (2001) 1095-1103
30. Platt R., Burdett W., and Roth J.A. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine. Am J Vet Res 67 (2006) 1179-1184